CN
586-39-0
应用筛选条件
关键词:'586-39-0'
显示 1-16 共 16 条结果 关于 "586-39-0" 范围 技术文档
Aldrich Polymer Products Application - Poss
T.L. J. Am. Chem.Soc. 1994,116, 2145.
(10) Edelman, F.T. Angew. Chem. Int. Ed. Engl. 1992, 31, 586.
(11) Feher, F.J. et al. J. Am. Chem. Soc. 1991, 113, 3618.
(12) Feher, F.J. et al. ibid. 1986
Quantitative PCR Product Listing
R
O
r
d
e
r
:
1
.
8
0
0
.
3
2
5
.
3
0
1
0
T
e
c
h
n
i
c
a
l
S
e
r
v
Protocol- PRCYTA-40K|PRCYTA-40K-PX38|PRCYTA-40K-BK38|PRCYTA-40K-PX48|PRCYTA-40K-BK48
TNFα
(pg/mL)
Standard 1 24.41 2.44 36.62 4.88
Standard 2 98 9.77 146 20
Standard 3 391 39 586 78
Standard 4 1,563 156 2,344 313
Standard 5 6,250 625
hKir2.1-HEK293 Recombinant Cell Line
Pharmacology. XLI. Compendium of voltage-gated ion
channels: potassium channels Pharmacol Rev 55(4), 583-586
Hume, J. R. and Uehara, A. (1985) Ionic basis of the different action potential
configurations
Protocol: Human Bone Magnetic Bead Panel
(pg/mL)
IL-1
(pg/mL)
FGF23
(pg/mL)
Standard 1 146 98 24 1 9
Standard 2 586 391 98 3 37
Standard 3 2,344 1,563 391 12 146
Protocol- HBNMAG-51K
(pg/mL)
IL-1β
(pg/mL)
FGF23
(pg/mL)
Standard 1 146 98 24 1 9
Standard 2 586 391 98 3 37
Standard 3 2,344 1,563 391 12 146
Non-Human Primate Cytokine/Chemokine/Growth Factor Panel A Magnetic Bead Panel
(pg/mL)
Standard 1 24.41 2.44 36.62 4.88
Standard 2 98 9.77 146 20
Standard 3 391 39 586 78
Standard 4 1,563 156 2,344 313
Standard 5 6,250 625 9,375
Human Immuno-Oncology Checkpoint Protein Panel 2
6.10 36.6 366 61.0 2.44
Standard 2 73.2 5 24.4 146.5 1465 244 9.77
Standard 3 293 20 97.7 586 5859 977 39.1
Standard 4 1,172 78 391 2,344 23,438 3,906 156
Protocol: Mouse Bone Magnetic Bead Panel --96-Well Plate Assay
Leptin
(pg/mL)
SOST & TNF-α
(pg/mL)
Standard 1 37 10 3
Standard 2 146 39 12
Standard 3 586 156 47
Standard 4 2,344 625
Protocol- MBNMAG-41K
Leptin
(pg/mL)
SOST & TNF-α
(pg/mL)
Standard 1 37 10 3
Standard 2 146 39 12
Standard 3 586 156 47
Standard 4 2,344 625 188
Integration of Experimental and Computational Microfluidics in 3D Tissue Engineering
al., “Study of Osteoblastic Cells in a Microfluidic Environment,” Biomaterials, Vol. 27,
2006, pp. 586–595.
[20] Wu, H. W., et al., “The Culture and Differentiation of Amniotic Stem Cells Using a Microfluidic
Chicken Cytokine/Chemokine Panel
1 7.32 3.66 18.3 24.4 36.6 48.8
Standard 2 29 14.6 73 98 147 195
Standard 3 117 59 293 391 586 781
Standard 4 469 234 1,172 1,563 2,344 3,125
Standard
Organic and Molecular Electronics
.70
BSB-Me 505 92±3 1.0 9.1 0.78±0.10 2.66
BSB-OMe 530 90±1 1.2 7.2 0.90±0.10 2.33
BSB-CN 586 55±2 1.5 3.7 2.35±0.10 1.84
The ASE thresholds are not directly correlated with φf or τf but are
XP725 Antibody List 013M4793
25023 Prkcb1 NP_036845.2 M n/d n/d y
585 Protein Kinase Cγ P8083 24681 Prkcc NP_036760.1 M n/d n/d y
586 Protein Kinase Cδ P8333 170538 Prkcd NP_579841.1 P n/d n/d y
587 Protein Kinase Cε P8458 29340 Prkce
XP725 Antibody List
25023 Prkcb1 NP_036845.2 M n/d n/d y
585 Protein Kinase Cγ P8083 24681 Prkcc NP_036760.1 M n/d n/d y
586 Protein Kinase Cδ P8333 170538 Prkcd NP_579841.1 P n/d n/d y
587 Protein Kinase Cε P8458 29340 Prkce
Cytoskeletal Signaling Antibodies, Reagents and Kits
Assay
20-196 Ral Activation
Assay Buffer, 5X
14-415 Ral Assay
Reagent (RAL BP1,
Agarose)
05-586 anti-RalA
04-037 anti-RalB,
clone 25
21-189 RalA
cDNA (active)
21-187 RalA cDNA
(dominant